• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

庞贝病伴运动神经元病的临床特征。

Clinical features of Pompe disease with motor neuronopathy.

机构信息

Department of Neurology, National Taiwan University Hospital, Taipei, Taiwan.

Department of Medical Genetics, National Taiwan University Hospital, Room 19005, 19F, Children's Hospital Building, 8 Chung-Shan South Road, Taipei 10041, Taiwan; Department of Pediatrics, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.

出版信息

Neuromuscul Disord. 2019 Nov;29(11):903-906. doi: 10.1016/j.nmd.2019.09.011. Epub 2019 Sep 25.

DOI:10.1016/j.nmd.2019.09.011
PMID:31706699
Abstract

Pathological studies on rodent models and patients with Pompe disease have demonstrated the accumulation of glycogen in spinal motor neurons; however, this finding has rarely been evaluated clinically in patients with Pompe disease. In this study, we analyzed seven patients (age, 7-11 years) with Pompe disease who received long-term enzyme replacement therapy. In addition to traditional myopathy-related clinical and electrophysiological features, these patients often developed bilateral foot drop, distal predominant weakness of four limbs, and hypo- or areflexia with preserved sensory function. Electrophysiological studies showed not only reduced amplitudes of compound muscle action potential, but also absent or impersistent F waves and mixed small and large/giant polyphasic motor unit action potentials with normal sensory study. Muscle biopsy usually showed the existence of angular fingers, fiber type grouping or group atrophy. Taken together, these features support the co-existence of motor neuronopathy additionally to myopathy.

摘要

对庞贝病啮齿动物模型和患者的病理学研究表明,糖原在脊髓运动神经元中积累;然而,这一发现很少在庞贝病患者的临床中得到评估。在这项研究中,我们分析了 7 名(年龄 7-11 岁)接受长期酶替代治疗的庞贝病患者。除了传统的肌病相关的临床和电生理特征外,这些患者还经常出现双侧足下垂、四肢远端为主的无力以及感觉功能正常的低反射或无反射。电生理研究显示,不仅复合肌肉动作电位的幅度降低,而且 F 波缺失或不持久,混合小和大/巨大多相运动单位动作电位正常。肌肉活检通常显示存在角状纤维、纤维类型分组或组萎缩。综上所述,这些特征支持运动神经元病与肌病同时存在。

相似文献

1
Clinical features of Pompe disease with motor neuronopathy.庞贝病伴运动神经元病的临床特征。
Neuromuscul Disord. 2019 Nov;29(11):903-906. doi: 10.1016/j.nmd.2019.09.011. Epub 2019 Sep 25.
2
Severe distal muscle involvement and mild sensory neuropathy in a boy with infantile onset Pompe disease treated with enzyme replacement therapy for 6 years.经酶替代治疗 6 年的婴儿起病 Pompe 病患儿出现严重的远端肌肉受累和轻度感觉性周围神经病。
Neuromuscul Disord. 2019 Jun;29(6):477-482. doi: 10.1016/j.nmd.2019.03.004. Epub 2019 Mar 14.
3
Prospective exploratory muscle biopsy, imaging, and functional assessment in patients with late-onset Pompe disease treated with alglucosidase alfa: The EMBASSY Study.接受阿糖苷酶α治疗的晚发型庞贝病患者的前瞻性探索性肌肉活检、影像学及功能评估:EMBASSY研究
Mol Genet Metab. 2016 Sep;119(1-2):115-23. doi: 10.1016/j.ymgme.2016.05.013. Epub 2016 May 19.
4
Safety and efficacy of alternative alglucosidase alfa regimens in Pompe disease.替代型阿糖苷酶α方案治疗庞贝病的安全性和有效性
Neuromuscul Disord. 2015 Apr;25(4):321-32. doi: 10.1016/j.nmd.2014.12.004. Epub 2014 Dec 19.
5
A Neuron-Specific Gene Therapy Relieves Motor Deficits in Pompe Disease Mice.神经元特异性基因治疗可缓解庞贝病小鼠的运动障碍。
Mol Neurobiol. 2018 Jun;55(6):5299-5309. doi: 10.1007/s12035-017-0763-4. Epub 2017 Sep 11.
6
Long-term intravenous treatment of Pompe disease with recombinant human alpha-glucosidase from milk.使用源自牛奶的重组人α-葡萄糖苷酶对庞贝氏病进行长期静脉治疗。
Pediatrics. 2004 May;113(5):e448-57. doi: 10.1542/peds.113.5.e448.
7
The clinical and electrodiagnostic characteristics of Pompe disease with post-enzyme replacement therapy findings.接受酶替代治疗后的庞贝病的临床和电诊断特征。
Clin Neurophysiol. 2011 Nov;122(11):2312-7. doi: 10.1016/j.clinph.2011.04.016. Epub 2011 May 13.
8
Perioperative management of children with glycogen storage disease type II-Pompe disease.II型糖原贮积病(庞贝病)患儿的围手术期管理
Paediatr Anaesth. 2018 May;28(5):428-435. doi: 10.1111/pan.13361. Epub 2018 Mar 25.
9
Reveglucosidase alfa (BMN 701), an IGF2-Tagged rhAcid α-Glucosidase, Improves Respiratory Functional Parameters in a Murine Model of Pompe Disease.瑞维葡糖苷酶α(BMN 701),一种IGF2标记的重组酸性α-葡萄糖苷酶,可改善庞贝病小鼠模型的呼吸功能参数。
J Pharmacol Exp Ther. 2017 Feb;360(2):313-323. doi: 10.1124/jpet.116.235952. Epub 2016 Nov 16.
10
Long-term enzyme-replacement therapy (ERT) with alglucosidase alfa: Evolution of two siblings with juvenile late-onset Pompe disease.用阿糖苷酶α进行长期酶替代疗法(ERT):两名青少年晚发型庞贝病患者的病情演变
J Neurol Sci. 2015 Nov 15;358(1-2):459-60. doi: 10.1016/j.jns.2015.08.007. Epub 2015 Aug 7.

引用本文的文献

1
Mitochondrial Dysfunction in Glycogen Storage Disorders (GSDs).糖原贮积症(GSDs)中的线粒体功能障碍。
Biomolecules. 2024 Sep 1;14(9):1096. doi: 10.3390/biom14091096.
2
Brain glycogen build-up measured by magnetic resonance spectroscopy in classic infantile Pompe disease.通过磁共振波谱法测量经典型婴儿庞贝病中的脑糖原蓄积。
Brain Commun. 2024 Sep 12;6(5):fcae303. doi: 10.1093/braincomms/fcae303. eCollection 2024.
3
Neurofilament Light and Its Association With CNS Involvement in Patients With Classic Infantile Pompe Disease.
神经丝轻链及其与经典婴儿型庞贝病患者中枢神经系统受累的关系。
Neurology. 2023 Aug 8;101(6):e594-e601. doi: 10.1212/WNL.0000000000207482. Epub 2023 Jun 19.
4
Degeneration of muscle spindles in a murine model of Pompe disease.庞贝病小鼠模型中的肌梭变性。
Sci Rep. 2023 Apr 21;13(1):6555. doi: 10.1038/s41598-023-33543-y.
5
[Research progress of nervous system damage in Pompe disease].庞贝病神经系统损害的研究进展
Zhongguo Dang Dai Er Ke Za Zhi. 2023 Apr 15;25(4):420-424. doi: 10.7499/j.issn.1008-8830.2211052.
6
Motor Responses in Pediatric Pompe Disease in the ADVANCE Participant Cohort.小儿庞贝病 ADVANCE 参与者队列的运动反应。
J Neuromuscul Dis. 2022;9(6):713-730. doi: 10.3233/JND-210784.
7
Pompe disease: pathogenesis, molecular genetics and diagnosis.庞贝病:发病机制、分子遗传学和诊断。
Aging (Albany NY). 2020 Aug 3;12(15):15856-15874. doi: 10.18632/aging.103794.